Premium
O3–06–06: The neuroprotective and neurotrophic agent T‐817MA for Alzheimer's disease: Randomized, double‐blind, placebo‐controlled proof‐of‐concept trial outcomes
Author(s) -
Schneider Lon,
Porsteinsson Anton,
Farlow Martin,
Shimakura Akira,
Nakagawa Masaya,
Iwakami Noboru
Publication year - 2013
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2013.04.272
Subject(s) - donepezil , placebo , medicine , memantine , neuroprotection , clinical trial , population , neurotoxicity , randomized controlled trial , anesthesia , pharmacology , nmda receptor , toxicity , dementia , disease , pathology , alternative medicine , receptor , environmental health